A UAB researcher’s involvement in clinical trials helped approve a first-of-its-kind targeted medication to reduce pain crisis for individuals with sickle cell disease.
Community members from Beaufort, South Carolina, trained palliative care physicians on how to have culturally appropriate conversations with their patients based on their backgrounds and ethnicities.
A first-of-its-kind newborn mouse model will permit study of how to protect extremely low birth-weight infants from bronchopulmonary dysplasia, or BPD.
Researchers have hired local community health care workers to collect samples from children for testing — and will provide treatment — if it is found that children living in several Alabama Black Belt counties are infected with hookworm, and related intestinal infections.
This study shows, for the first time, that CFTR existed with the basic function as an ion channel earlier than the ancient split between jawed and jawless vertebrates.
A study conducted by UAB investigators reports a decline in cholesterol levels since the 2013 cholesterol guidelines, but more needs to be done in the way of improving cardiovascular health.
Researchers will study innovative strategies to better engage populations most at risk, most vulnerable, and least likely to have access to eye care to detect and manage glaucoma and other eye diseases in community-based settings.
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.